Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Cohen, Stanley B
8584  Ergebnisse:
Personensuche X
?
1

Safety profile of upadacitinib over 15 000 patient-years ac..:

Burmester, Gerd R ; Cohen, Stanley B ; Winthrop, Kevin L...
RMD Open.  9 (2023)  1 - p. e002735 , 2023
Link: https://doi.org/10.1136/..
 
?
2

Biosimilars for Rheumatoid Arthritis: Riding the 2023 Wave ..:

Cohen, Stanley B ; Leach, Mariah
Open Access Rheumatology: Research and Reviews.  15 (2023)  - p. 207-212 , 2023
Link: https://doi.org/10.2147/..
 
?
3

Correction: Post-Marketing Safety Surveillance of Tofacitin..:

Burmester, Gerd R. ; Coates, Laura C. ; Cohen, Stanley B....
Rheumatology and Therapy.  11 (2023)  1 - p. 221-222 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Post-Marketing Safety Surveillance of Tofacitinib over 9 Ye..:

Burmester, Gerd R. ; Coates, Laura C. ; Cohen, Stanley B....
Rheumatology and Therapy.  10 (2023)  5 - p. 1255-1276 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Impact of Methotrexate Discontinuation, Interruption, or Pe..:

Cohen, Stanley B. ; Haraoui, Boulos ; Curtis, Jeffrey R....
Clinical Therapeutics.  44 (2022)  7 - p. 982-997.e2 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Effect of dose adjustments on the efficacy and safety of to..:

Mueller, Ruediger B. ; Schulze-Koops, Hendrik ; Furst, Daniel E....
Clinical Rheumatology.  41 (2022)  4 - p. 1045-1055 , 2022
Link: https://doi.org/10.1007/..
 
?
7

P220 Long-term safety profile of upadacitinib in patients w..:

Shaw, Tim ; Burmester, Gerd R ; Cohen, Stanley B...
Rheumatology.  61 (2022)  Supplement_1 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
8

Plain Language Summary of the VOLTAIRE-RA in Patients with ..:

Cohen, Stanley B ; Lee, Eric C
Immunotherapy.  14 (2022)  15 - p. 1183-1190 , 2022
Link: https://doi.org/10.2217/..
 
?
9

Oral surveillance and JAK inhibitor safety: the theory of r..:

Winthrop, Kevin L. ; Cohen, Stanley B.
Nature Reviews Rheumatology.  18 (2022)  5 - p. 301-304 , 2022
Link: https://doi.org/10.1038/..
 
?
10

Tu1454: THE SAFETY PROFILE OF UPADACITINIB MAINTENANCE THER..:

Colombel, Jean Frederic ; Panaccione, Remo ; Nakase, Hiroshi...
Gastroenterology.  162 (2022)  7 - p. S-967-S-968 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Influenza Adverse Events in Patients with Rheumatoid Arthri..:

Winthrop, Kevin L. ; Yndestad, Arne ; Henrohn, Dan...
Rheumatology and Therapy.  10 (2022)  2 - p. 357-373 , 2022
Link: https://doi.org/10.1007/..
 
?
12

JAK inhibitors and VTE risk: how concerned should we be?:

Cohen, Stanley B.
Nature Reviews Rheumatology.  17 (2021)  3 - p. 133-134 , 2021
Link: https://doi.org/10.1038/..
 
?
13

Efficacy and safety of tofacitinib modified-release 11 mg o..:

Cohen, Stanley B ; Pope, Janet ; Haraoui, Boulos...
RMD Open.  7 (2021)  2 - p. e001673 , 2021
Link: https://doi.org/10.1136/..
 
?
14

Adverse events of special interest in clinical trials of rh..:

Burmester, Gerd R ; Nash, Peter ; Sands, Bruce E...
RMD Open.  7 (2021)  2 - p. e001595 , 2021
Link: https://doi.org/10.1136/..
 
?
15

Clinical utility of therapy selection informed by predicted..:

Strand, Vibeke ; Cohen, Stanley B. ; Curtis, Jeffrey R....
Expert Review of Molecular Diagnostics.  22 (2021)  1 - p. 101-109 , 2021
Link: https://doi.org/10.1080/..
 
1-15